Eric Trachtenberg's Net Worth

$565 Thousand

Estimate Recalculated Dec 3, 2025 07:32PM EST

Who is Eric Trachtenberg

Eric Trachtenberg does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KALA BIO, Inc., Aralez Pharmaceuticals Inc., and POZEN INC /NC.

SEC CIK

Eric Trachtenberg's CIK is 0001646300

Past Insider Trading and Trends

2016 was Eric Trachtenberg's most active year for acquiring shares with 5 total transactions. Eric Trachtenberg's most active month to acquire stocks was the month of December. 2023 was Eric Trachtenberg's most active year for disposing of shares, totalling 8 transactions. Eric Trachtenberg's most active month to dispose stocks was the month of April. 2020 saw Eric Trachtenberg paying a total of $149,996.19 for 225,901 shares, this is the most they've acquired in one year. In 2021 Eric Trachtenberg cashed out on 11,901 shares for a total of $31,156.24, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KALA BIO, Inc.

SEE REMARKS
Updated Jan 05, 2024
Form 4
36.90%
23.87K
$6.74
-$8.27K
Jan 05, 2024
88.57K
Grant
Jan 04
Form 4
322.98%
87.64K
Jun 23, 2023
114.77K
Grant
Jun 22
Form 4
Jun 02, 2023
27.13K
Acq/Dis
May 31
Form 4
432.00
Mar 15, 2023
432.00
Grant
Mar 14
Form 4
466.26%
9.46K
$28.55
-$1.71K
Jan 06, 2023
11.50K
Grant
ScheduledJan 04
Form 4
-8.72%
-194.00
$6.52
-$1.26K
Oct 28, 2022
2.03K
Sale
ScheduledOct 26
Form 4
-2.30%
-2.61K
$0.37
-$966.81
Jun 29, 2022
111.20K
Sale
ScheduledJun 27
Form 4
128.70%
150.15K
$1.30
-$3.70K
Jan 05, 2022
266.82K
Grant
ScheduledJan 03 - Jan 04
Form 4
-7.49%
-9.45K
$1.80
-$17.01K
Oct 28, 2021
116.67K
Sale
ScheduledOct 26
Form 4
-1.91%
-2.45K
$5.77
-$14.15K
Jun 29, 2021
126.12K
Sale
ScheduledJun 28
Form 4
107.02%
113.33K
Jan 05, 2021
219.23K
Grant
Jan 04
Form 4
135.85%
61.00K
Oct 28, 2020
105.90K
Grant
Oct 26
Form 4
55.36%
16.00K
Jun 29, 2020
44.90K
Grant
Jun 25
Form 4
$5.19
$150.00K
Jun 22, 2020
165.00K
Options
Jun 19
Form 4
120.00K
Jan 03, 2020
120.00K
Grant
Jan 02
Form 4
100.00K
Oct 15, 2019
100.00K
Grant
Oct 12
Form 4
165.00K
Jan 04, 2019
165.00K
Grant
Jan 02
Form 4
150.00K
Apr 09, 2018
150.00K
Grant
Apr 05
Form 3
Apr 09, 2018
Showing 19 results

Aralez Pharmaceuticals Inc.

GC, CCO & Secretary
Updated Mar 21, 2018
Form 4
-1.72%
-3.47K
$1.70
-$5.90K
Mar 21, 2018
198.09K
Sale
ScheduledMar 19
Form 4
-3.69%
-7.72K
$1.33
-$10.27K
Jun 23, 2017
201.56K
Sale
ScheduledJun 23
Form 4
96.63%
139.63K
May 12, 2017
284.14K
Grant
May 11
Form 4
7.43%
10.00K
$3.76
$37.57K
May 18, 2016
144.50K
Purchase
May 16
Form 4
63.70%
63.70K
Mar 18, 2016
163.70K
Grant
Mar 17
Form 4
300.00%
75.00K
Feb 17, 2016
100.00K
Grant
Feb 12
Form 4
25.00K
Feb 09, 2016
25.00K
Acq/Dis
Feb 05
Showing 7 results

POZEN INC /NC

Deputy General Counsel
Updated Jun 25, 2015
Form 4
25.00K
Jun 25, 2015
25.00K
Grant
Jun 22
Form 3
Jun 25, 2015
Showing 2 results